You searched for "cancers"

2027 results found

Robotic surgery for squamous cell cancer: the new frontiers

Although the da Vinci platform was FDA approved for early-stage oropharyngeal cancers, the indications have expanded. In this article, John Hardman explains how surgeons, with greater understanding of the strengths and limitations of robotic surgery, have systematically set out to...

Clinical leadership and management: developing world ENT

I have been asked to share some of the initiatives I have been involved with to address ENT-related challenges in Africa and the developing world. Developing countries constitute the majority of the world’s landmass (Figure 1), are home to >50%...

In conversation with Professor Jatin Shah

We are honoured to welcome renowned head and neck surgeon, Professor Jatin Shah as Guest Editor of this edition of ENT and Audiology News. Here he speaks to Section Editor, Charlie Giddings, about his career, memorable achievements and advice for...

Treatment regret in head and neck cancer – trading function for survival

Treatment for H&N cancer can be extremely tough for patients. How do we explain the likely impact as they try to make decisions? And what happens when they regret their choice? Treatment regret is a is a form of decision...

Giacomo Puccini’s laryngeal cancer

Giacomo Puccini, one of the best known composers of all time, was diagnosed with laryngeal cancer and died from the disease in 1924. In this article, Rosario Marchese-Ragona and Alessandro Martini describe Puccini’s experience of the disease with quotes from...

Changing perceptions in head and neck cancer management caused by quality of life issues

Sir Felix Semon was an outstanding clinician and exceptional laryngologist. The money raised by donations from his colleagues on his retirement in 1909 was used to establish the London University’s Semon Lecture. Semon’s Obituary in the BMJ, reads: “In Semon's...

ENT UK Head & Neck Meeting

The ENT UK Head and Neck Evidence-Based Management Meeting focusing on malignancy of the nose and paranasal sinuses was held in the historic market town of York. The multidisciplinary approach required to manage this complex disease was reflected in the speaker lineup, with national representation from ENT, maxillofacial and plastic surgery, oncology, palliative medicine, histopathology and radiology.

Importance of the time interval between surgery and postoperative radiation therapy in head and neck cancer

The ideal time to start postoperative radiation therapy (PORT) in head and neck cancer patients has been an issue of debate. In the USA, the National Comprehensive Cancer Network (NCCN) recommends initiating radiotherapy within six weeks from surgery. The six-week...

ManCAD Research CAPers Conference

ManCAD's upcoming inaugural research conference has been playfully named ‘Research CAPers’ – as in Research Clinical Auditory Papers. This year’s conference highlighted the scientific accomplishments of Professor Dave Moore – who is retiring later this year from his various academic roles.

8th International Head & Neck Cancer Conference

Chris Byrne, Advocate for The Swallows head and neck cancer charity and tongue cancer survivor. A typical cancer conference is all data-heavy PowerPoint presentations on the finer points of the latest research. Not so at this event run by The...

Surgical challenges in advanced or recurrent thyroid malignancy

The management of thyroid malignancy and extent of surgery is controversial, especially considering the limitations of preoperative diagnosis. Neil Tolley provides guidance and reminds us of our responsibility not to over-treat. In the UK, 16% of thyroidectomies are performed for...